311 related articles for article (PubMed ID: 33373871)
21. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study.
Arndt V; Stegmaier C; Ziegler H; Brenner H
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1311-8. PubMed ID: 18504613
[TBL] [Abstract][Full Text] [Related]
22. Internal Responsiveness of EQ-5D-5L and EORTC QLQ-C30 in Dutch Breast Cancer Patients during the First Year Post-Surgery: A Longitudinal Cohort Study.
Vrancken Peeters NJMC; van Til JA; Huberts AS; Siesling S; Husson O; Koppert LB
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893073
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Schramm A; Schochter F; Friedl TWP; de Gregorio N; Andergassen U; Alunni-Fabbroni M; Trapp E; Jaeger B; Heinrich G; Camara O; Decker T; Ober A; Mahner S; Fehm TN; Pantel K; Fasching PA; Schneeweiss A; Janni W; Rack BK;
Clin Breast Cancer; 2017 Jul; 17(4):279-285. PubMed ID: 28190761
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
Schwartzberg L; McIntyre K; Wilks S; Puhalla S; O'Shaughnessy J; Berrak E; He Y; Vahdat L
BMC Cancer; 2019 Jun; 19(1):578. PubMed ID: 31195996
[TBL] [Abstract][Full Text] [Related]
25. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
[TBL] [Abstract][Full Text] [Related]
26. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Robson M; Ruddy KJ; Im SA; Senkus E; Xu B; Domchek SM; Masuda N; Li W; Tung N; Armstrong A; Delaloge S; Bannister W; Goessl C; Degboe A; Hettle R; Conte P
Eur J Cancer; 2019 Oct; 120():20-30. PubMed ID: 31446213
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.
Verma S; O'Shaughnessy J; Burris HA; Campone M; Alba E; Chandiwana D; Dalal AA; Sutradhar S; Monaco M; Janni W
Breast Cancer Res Treat; 2018 Aug; 170(3):535-545. PubMed ID: 29654415
[TBL] [Abstract][Full Text] [Related]
28. Breast Cancer Quality of Life and Health-state Utility at a Brazilian Reference Public Cancer Center.
Guerra RL; Dos Reis NB; Corrêa FM; Fernandes MM; Ribeiro Alves Fernandes R; Cancela MC; Araújo RM; Crocamo S; Santos M; De Almeida LM
Expert Rev Pharmacoecon Outcomes Res; 2020 Apr; 20(2):185-191. PubMed ID: 31106611
[No Abstract] [Full Text] [Related]
29. Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival.
Monteiro MR; Nunes NCC; Crespo J; Abrahão ABK; Buscacio G; Lerner LCC; Sermoud L; Arakelian R; Piotto G; Lemos C; Campos R; Victorino D; Andrade PM; Ferreira TAV; Pecoraro JP; Meton F; Gaui MF; Araujo LH
Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):608-616. PubMed ID: 35667940
[TBL] [Abstract][Full Text] [Related]
30. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
[TBL] [Abstract][Full Text] [Related]
31. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
Kim EJ; Ko SK; Kang HY
Qual Life Res; 2012 Sep; 21(7):1193-203. PubMed ID: 22012023
[TBL] [Abstract][Full Text] [Related]
32. Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
Passildas J; Collard O; Savoye AM; Dohou J; Ginzac A; Thivat E; Durando X; Kwiatkowski F; Penault-Llorca F; Abrial C; Mouret-Reynier MA
Clin Breast Cancer; 2019 Feb; 19(1):e74-e84. PubMed ID: 30448088
[TBL] [Abstract][Full Text] [Related]
33. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
Osoba D; Zee B; Pater J; Warr D; Kaizer L; Latreille J
Qual Life Res; 1994 Oct; 3(5):353-64. PubMed ID: 7841968
[TBL] [Abstract][Full Text] [Related]
34. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
Laquente B; Macarulla T; Bugés C; Martín M; García C; Pericay C; Merino S; Visa L; Martín T; Pedraza M; Carnero B; Guardeño R; Verdaguer H; Mut A; Vilanova D; García A
BMC Palliat Care; 2020 Jul; 19(1):103. PubMed ID: 32650765
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
36. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life.
Wyld L; Reed MWR; Morgan J; Collins K; Ward S; Holmes GR; Bradburn M; Walters S; Burton M; Herbert E; Lifford K; Edwards A; Ring A; Robinson T; Martin C; Chater T; Pemberton K; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter M; Naik J; Parmeshwar R; Patnick J; Gosney M; Hatton M; Thomson AM
Eur J Cancer; 2021 Jan; 142():48-62. PubMed ID: 33220653
[TBL] [Abstract][Full Text] [Related]
37. Correlations between state anxiety and quality of life in metastatic breast cancer patients.
Dragomir BI; Fodoreanu L
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):610-5. PubMed ID: 24502024
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Sibhat SG; Fenta TG; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
[TBL] [Abstract][Full Text] [Related]
39. Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer.
Adjogatse D; Thanopoulou E; Okines A; Thillai K; Tasker F; Johnston SR; Harper-Wynne C; Torrisi E; Ring A
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):692-6. PubMed ID: 24909701
[TBL] [Abstract][Full Text] [Related]
40. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
